Ascend Advanced Therapies Funding: $130M Raised, Series A
Ascend Advanced Therapies is based in Rockville, Maryland. It has raised $130M in total funding. Latest round: Series A.
Ascend Advanced Therapies funding overview
Ascend Advanced Therapies is based in Rockville, Maryland. Ascend Advanced Therapies has raised $130M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in January 2023. The round record for Ascend Advanced Therapies runs through 2023; nothing later has been disclosed. Investors on record include Abingworth, Petrichor, DCVC Bio, 4BIO Capital, Cathay Health, Deerfield Management and 3 others. 9 distinct backers are named across the disclosed rounds.
Frequently asked about Ascend Advanced Therapies funding
How much has Ascend Advanced Therapies raised?
Ascend Advanced Therapies has raised $130M in total disclosed funding across the rounds on record.
Who has invested in Ascend Advanced Therapies?
Abingworth, Petrichor, DCVC Bio, 4BIO Capital, Cathay Health, Deerfield Management are named among the investors backing Ascend Advanced Therapies.
What was the latest Ascend Advanced Therapies funding round?
The most recent disclosed round is a Series A, announced in January 2023.
Where is Ascend Advanced Therapies based?
Ascend Advanced Therapies is based in Rockville, Maryland.
When did Ascend Advanced Therapies last raise?
The last disclosed Ascend Advanced Therapies round closed in January 2023 at Series A.
Round data for Ascend Advanced Therapies is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Rockville and backer lists below.
Companies related to Ascend Advanced Therapies (29)
